Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NADROPARIN for Coagulopathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where NADROPARIN was used for Coagulopathy.

Most Reported Side Effects for NADROPARIN

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 81 12.0% 5 21
Off label use 77 11.4% 17 44
Premature baby 73 10.8% 3 30
Maternal exposure during pregnancy 72 10.7% 1 25
Drug ineffective 54 8.0% 3 25
Sepsis 46 6.8% 0 45
Dyspnoea 44 6.5% 2 29
Fall 43 6.4% 0 42
Exposure during pregnancy 42 6.2% 0 5
Confusional state 40 5.9% 19 26
Diarrhoea 34 5.0% 0 27
Hypertension 34 5.0% 19 19
Premature delivery 34 5.0% 0 7
Thrombocytopenia 33 4.9% 4 28
Platelet count decreased 32 4.7% 0 30

Other Indications for NADROPARIN

Product used for unknown indication (251) Thrombosis prophylaxis (79) Anticoagulant therapy (51) Prophylaxis (38) Covid-19 (23) Deep vein thrombosis (19) Venous thrombosis limb (19) Pulmonary embolism (17) Foetal exposure during pregnancy (16) Thrombosis (15)

Other Drugs Used for Coagulopathy

RIVAROXABAN (168) ASPIRIN (163) ENOXAPARIN (125) WARFARIN (112) CLOPIDOGREL BISULFATE (97) APIXABAN (71) HEPARIN (65) PHYTONADIONE (53) DALTEPARIN (43) DABIGATRAN ETEXILATE (42)

Related Pages

NADROPARIN Full Profile All Coagulopathy Drugs NADROPARIN Demographics NADROPARIN Timeline